Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Lisinopril + Hydrochlorothiazide
- Therapeutic area
- Cardiovascular
- Drug class
- Antihypertensive medicines
- ATC
- C09BA
- Strength
- 20 mg + 12.5 mg
- Dosage form
- Tablet
- Pack
- 14's
- Registration no.
- 049160
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-09-23 03:19
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 395.92 to 415.48 (+4.9%) between 18 Aug 2025 and 17 Aug 2026 · 2 official price records · pack 14's
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Co-Lispril 20 20 mg + 12.5 mg, 14's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/co-lispril-20-20-mg-12-5-mg-049160-14s-werrick-pharmaceuticals/ (accessed 23 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 415.48 | 2026-08-17 | 2026-09-22 | DRAP PharmaPrice Index (refreshed from snapshot #84) | Current |
| PKR 395.92 | 2025-08-18 | 2026-08-08 | DRAP PharmaPrice Index | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 049160Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.
